Antidiabetic effect of gemigliptin: a systematic review and meta-analysis of randomized controlled trials with Bayesian inference through a quality management system.

Oh, Hojin; Nguyen, Hai Duc; Yoon, In Mo; Ahn, Byung-Ryong; Kim, Min-Sun

Oh, Hojin; Nguyen, Hai Duc; Yoon, In Mo; Ahn, Byung-Ryong; Kim, Min-Sun.

Afiliação

Oh H; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Suncheon, Jeollanam-do, 57922, Republic of Korea.
Nguyen HD; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Suncheon, Jeollanam-do, 57922, Republic of Korea.
Yoon IM; Unimedi Plastic Surgery Clinic, Suite 302, 3rd Floor, 833 Nonhyeon-ro, Sinsa-dong, Gangnam-gu, Seoul, 06032, Republic of Korea.
Ahn BR; Korea Statistical Consulting, Suite 735, 7th Floor, 81 Sambong-ro, Jongno-gu, Seoul, 03150, Republic of Korea.
Kim MS; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Suncheon, Jeollanam-do, 57922, Republic of Korea. minsun@scnu.ac.kr.

Sci Rep ; 11(1): 20938, 2021 10 22.

Article em En | MEDLINE | ID: mdl-34686738

Assuntos

Hipoglicemiantes/farmacologia; Piperidonas/farmacologia; Pirimidinas/farmacologia; Animais; Teorema de Bayes; Humanos; Metformina/farmacologia; Ensaios Clínicos Controlados Aleatórios como Assunto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidonas / Pirimidinas / Hipoglicemiantes Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google